Gregory Kruse

806 total citations
23 papers, 505 citations indexed

About

Gregory Kruse is a scholar working on Economics and Econometrics, Surgery and General Health Professions. According to data from OpenAlex, Gregory Kruse has authored 23 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 4 papers in Surgery and 4 papers in General Health Professions. Recurrent topics in Gregory Kruse's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Lipoproteins and Cardiovascular Health (4 papers) and Healthcare Policy and Management (4 papers). Gregory Kruse is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Lipoproteins and Cardiovascular Health (4 papers) and Healthcare Policy and Management (4 papers). Gregory Kruse collaborates with scholars based in United States, United Kingdom and Switzerland. Gregory Kruse's co-authors include Gerald A. McDermott, Rafael A. Corredoira, Rachel M. Werner, R. Tamara Konetzka, Bruce Wong, Éric Bruckert, Lucie Kutikova, Kausik K. Ray, Pedro Mata and Zhen Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Academy of Management Journal and American Heart Journal.

In The Last Decade

Gregory Kruse

21 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Kruse United States 9 194 119 105 71 58 23 505
Nicola Burgess United Kingdom 13 106 0.5× 145 1.2× 209 2.0× 33 0.5× 41 0.7× 27 855
José Molero Spain 15 158 0.8× 51 0.4× 193 1.8× 36 0.5× 32 0.6× 96 795
Jane Bourke Ireland 14 120 0.6× 57 0.5× 136 1.3× 25 0.4× 66 1.1× 44 638
Kathy GermAnn Canada 7 31 0.2× 208 1.7× 67 0.6× 84 1.2× 28 0.5× 15 587
Manuel García‐Goñi Spain 13 208 1.1× 182 1.5× 55 0.5× 9 0.1× 42 0.7× 35 574
Roberto Ippoliti Italy 14 324 1.7× 37 0.3× 75 0.7× 30 0.4× 22 0.4× 53 586
John L. Fortenberry United States 14 70 0.4× 206 1.7× 55 0.5× 36 0.5× 14 0.2× 34 647
Raquel Ortega Spain 14 56 0.3× 37 0.3× 29 0.3× 191 2.7× 88 1.5× 52 738
İbrahim Doğan Türkiye 14 202 1.0× 66 0.6× 67 0.6× 167 2.4× 7 0.1× 63 651
Corinna Sorenson United Kingdom 16 574 3.0× 313 2.6× 29 0.3× 38 0.5× 20 0.3× 41 877

Countries citing papers authored by Gregory Kruse

Since Specialization
Citations

This map shows the geographic impact of Gregory Kruse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Kruse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Kruse more than expected).

Fields of papers citing papers by Gregory Kruse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Kruse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Kruse. The network helps show where Gregory Kruse may publish in the future.

Co-authorship network of co-authors of Gregory Kruse

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Kruse. A scholar is included among the top collaborators of Gregory Kruse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Kruse. Gregory Kruse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Green-McKenzie, Judith, Frances S. Shofer, Gregory Kruse, et al.. (2023). COVID-19 vaccine uptake before and after a vaccine mandate at a major academic hospital: Trends by race/ethnicity and level of patient contact. Vaccine. 41(37). 5441–5446. 3 indexed citations
2.
Green-McKenzie, Judith, Frances S. Shofer, Florence Momplaisir, et al.. (2021). Factors Associated With COVID-19 Vaccine Receipt by Health Care Personnel at a Major Academic Hospital During the First Months of Vaccine Availability. JAMA Network Open. 4(12). e2136582–e2136582. 23 indexed citations
3.
Wechsler, Lawrence R., et al.. (2020). Reflections on a Health System's Telemedicine Marathon. SHILAP Revista de lepidopterología. 1(1). 2–7. 4 indexed citations
4.
Kruse, Gregory, Lucie Kutikova, Bruce Wong, et al.. (2017). Cardiovascular Disease Risk And Risk Factors Associated With Familial Hypercholesterolemia: A Systematic Review. Value in Health. 20(9). A606–A606. 4 indexed citations
5.
Wong, Bruce, Gregory Kruse, Lucie Kutikova, et al.. (2016). Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature. Clinical Therapeutics. 38(7). 1696–1709. 65 indexed citations
6.
Kruse, Gregory, Bruce Wong, Mei Sheng Duh, et al.. (2015). Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment. PharmacoEconomics. 33(10). 1049–1067. 2 indexed citations
7.
Wong, Bruce, Guillermo Villa, Lucie Kutikova, et al.. (2015). The Magnitude of Increased Cardiovascular (Cv) Risk Associated with Familial Hypercholesterolemia (Fh) for use in Economic Analyses. Value in Health. 18(7). A340–A340. 2 indexed citations
8.
Burns, Lawton R., Jeffrey S. McCullough, Douglas R. Wholey, et al.. (2015). Is the System Really the Solution? Operating Costs in Hospital Systems. Medical Care Research and Review. 72(3). 247–272. 36 indexed citations
9.
Kruse, Gregory, et al.. (2014). Administration costs of intravenous chemotherapy in treating peripheral T-cell lymphoma. Journal of Medical Economics. 17(7). 446–458. 3 indexed citations
10.
11.
Werner, Rachel M., R. Tamara Konetzka, & Gregory Kruse. (2008). Impact of Public Reporting on Unreported Quality of Care. Health Services Research. 44(2p1). 379–398. 57 indexed citations
12.
Kruse, Gregory, et al.. (2008). Analysis of Costs Associated With Administration of Intravenous Single-Drug Therapies in Metastatic Breast Cancer in a U.S. Population. Journal of Managed Care Pharmacy. 14(9). 844–857. 37 indexed citations
13.
Groeneveld, Peter W., Gregory Kruse, Zhen Chen, & David A. Asch. (2007). Variation in cardiac procedure use and racial disparity among Veterans Affairs Hospitals. American Heart Journal. 153(2). 320–327. 39 indexed citations
14.
Berndt, Ernst R., Patricia M. Danzon, & Gregory Kruse. (2007). Dynamic competition in pharmaceuticals: cross‐national evidence from new drug diffusion. Managerial and Decision Economics. 28(4-5). 231–250. 17 indexed citations
15.
McDermott, Gerald A., Rafael A. Corredoira, & Gregory Kruse. (2007). Public-Private Networks as Sources of Knowledge and Upgrading Capabilities: A Parametric Stroll through Argentine Vineyards. SSRN Electronic Journal. 8 indexed citations
16.
McDermott, Gerald A., Rafael A. Corredoira, & Gregory Kruse. (2007). PUBLIC-PRIVATE NETWORKS AND UPGRADING CAPABILITIES: A PARAMETRIC STROLL THROUGH ARGENTINE VINEYARDS.. Academy of Management Proceedings. 2007(1). 1–6. 1 indexed citations
17.
Kruse, Gregory. (2004). New wine in old bottles. Manufacturing Engineer. 83(3). 48–48. 4 indexed citations
18.
Kruse, Gregory. (2001). How will we fare in 2020 and beyond?. Manufacturing Engineer. 80(1). 38–42.
19.
Kruse, Gregory, et al.. (1984). [Attrition of the spinal column in agricultural technicians--results of a cross-sectional study].. PubMed. 78(13). 537–41. 2 indexed citations
20.
Myrtek, Michael, et al.. (1974). [Psychophysiology of orthostatic cardiovascular response].. PubMed. 63(11). 1034–50.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola Burgess Breakdown of academic impact, for papers by José Molero Breakdown of academic impact, for papers by Jane Bourke Breakdown of academic impact, for papers by Kathy GermAnn Breakdown of academic impact, for papers by Manuel García‐Goñi Breakdown of academic impact, for papers by Roberto Ippoliti Breakdown of academic impact, for papers by John L. Fortenberry Breakdown of academic impact, for papers by Raquel Ortega Breakdown of academic impact, for papers by İbrahim Doğan Breakdown of academic impact, for papers by Corinna Sorenson
Rankless by CCL
2026